N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide
C20H18FN5O2 — CID 155588704
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide
N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide (PubChem CID 155588704) has the molecular formula C20H18FN5O2 and a molecular weight of 379.40 g/mol. Its IUPAC name is N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 155588704 |
| Molecular Formula | C20H18FN5O2 |
| Molecular Weight | 379.40 g/mol |
| Exact Mass | 379.14 |
| IUPAC Name | N-(3-fluoro-1-bicyclo[1.1.1]pentanyl)-4-[[2-(1H-indazol-6-yl)acetyl]amino]pyridine-2-carboxamide |
| SMILES | O=C(Cc1ccc2cn[nH]c2c1)Nc1ccnc(C(=O)NC23CC(F)(C2)C3)c1 |
| InChI | InChI=1S/C20H18FN5O2/c21-19-9-20(10-19,11-19)25-18(28)16-7-14(3-4-22-16)24-17(27)6-12-1-2-13-8-23-26-15(13)5-12/h1-5,7-8H,6,9-11H2,(H,23,26)(H,25,28)(H,22,24,27) |
| InChIKey | IKFHGRDACLWHNJ-UHFFFAOYSA-N |
| XLogP | 2.51 |
| TPSA | 99.77 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 379.40 |
| LogP ≤ 5 | 2.51 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155588704 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.